PROJECTS FUNDED BY MEAGAN’S WALK
Meagan’s Walk is dedicated to funding research and initiatives that:
- Bring the top brain tumour experts all over the world together to share knowledge and to collaborate on research.
- Uncover when and how genetic mutations arise to cause brain tumours in children.
- Identify new, less toxic treatments for children with brain tumours, helping them live healthier lives.
FUNDED THIS YEAR
Meagan’s Walk Seed Operating Grant
Unravelling the DNA Damage Response Pathway in High Risk Ependymoma
Principal Investigator:Dr. Vijay Ramaswamy
Investigating the switch between quiescence and proliferation in the stem cell compartment of sonic hedgehog subgroup medulloblastoma
Principal Investigator: Dr. Peter Dirks
Methionine deprivation as a therapeutic strategy for diffuse intrinsic pontine glioma
led by Dr. Cynthia Hawkins
Splicing regulation of tumour suppressor activity in pediatric brain cancer
Principal Investigator: Dr. Jane McGlade
Application of next generation genomic tools to identify predictors of success and failure for infant brain tumour therapy
led by Dr. Annie Huang
Deciphering mechanical heterogeneity and its regulators for brain tumour therapeutics
Principal Investigator: Dr. Xi Huang
BTRC Pediatric Biologics Repository and Database for Brain Tumours
Principal Investigator: Dr. James Rutka
National Collaborative Seed Grant
ReRad:
A Phase II Study of Re-Irradiation of Treatment of Progressive Diuse Intrinsic Pontine Glioma with the Canadian Paediatric Brain Tumour Consortium of the Alberta Children’s Hospital and University of Calgary.
Health Related Quality of Life in Patients Diagnosed with Diuse Intrinsic Pontine Glioma and their Caregivers
in collaboration with Dr. Fiona Schulte of the Alberta Children’s Hospital
The Role of RNA Stress Granules in GBM Treatment Resistance
in collaboration with Dr. Weeks from Dalhousie University in Nova Scotia
The study of Medulloblastoma subgroup 3 Development
in collaboration with Dr. David Eisenstat from the University of Alberta
